Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes Mellitus Type 2 Clinical Trials

A listing of Diabetes Mellitus Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (924) clinical trials

The THEMIS clinical research study is evaluating a study drug to see if it may help prevent heart attack and stroke in people with type 2 diabetes.

Phase N/A

We can introduce you to investigational treatment options now available through clinical trials

Phase N/A

The INSTRIDE Studies are looking to see how well an investigational insulin works to control blood sugar levels. The investigational insulin has been designed to be as similar as possible to insulin glargine (Lantus®), which has helped many people with diabetes worldwide. The investigational insulin could be a more affordable ...

Phase N/A

If your child has type 2 diabetes that is difficult to control or if type 2 diabetes runs in your family, you may want to learn more about the SITup research studies. What is the purpose of the SITup studies? The purpose of the SITup studies is to find out ...

Phase N/A

This clinical trial compares insulin degludec to insulin glargine in type 2 diabetic patients with high risk of cardiovascular events. All subjects receive active medication-there is no placebo.

Phase

The purpose of this study is to test the safety of ertugliflozin and see what effects (good and bad) that it has on adults with Type 2 diabetes whose blood sugar is not well controlled while being treated with metformin and sitagliptin (Januvia).

Phase N/A

The purpose of this study is to compare the safety and effects (good and bad) of ertugliflozin compared with glimepiride on people with type 2 Diabetes Mellitus who are being treated with metformin with or without other diabetes medicines.

Phase N/A

A study to evaluate the effect of long-term treatment with Belviq® (Lorcaserin HCI) on the incidence of major adverse cardiovascular events and conversion to Type 2 Diabetes Mellitus in obese and overweight subjects with cardiovascular disease or multiple cardiovascular risk factors. Half of the patients will be randomly assigned to ...

Phase

The purpose of the study is to evaluate whether a new antiplatelet therapy, Brilinta® (Ticagrelor) approved by the FDA, for the reduction of major cardiovascular events in patients with certain heart conditions, is effective in preventing the occurrence of heart attack, stroke and/or death due to cardiovascular events in patients ...

Phase

We are enrolling adult volunteers now. Help us explore pathways to diabetes management If you have type 2 diabetes, and are between 18 and 75 years of age, find out if you qualify for a clinical research study of an investigational oral diabetes medication.

Phase N/A